These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18650448)

  • 41. Synthesis of recombinant blood coagulation factor VIII (FVIII) heavy and light chains and reconstitution of active form of FVIII.
    Oh SH; Lee MY; Song DW
    Exp Mol Med; 1999 Jun; 31(2):95-100. PubMed ID: 10410309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.
    Marquette KA; Pittman DD; Kaufman RJ
    J Biol Chem; 1995 Apr; 270(17):10297-303. PubMed ID: 7730335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy.
    Hakeos WH; Miao H; Sirachainan N; Kemball-Cook G; Saenko EL; Kaufman RJ; Pipe SW
    Thromb Haemost; 2002 Nov; 88(5):781-7. PubMed ID: 12428094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXa.
    Fay PJ; Scandella D
    J Biol Chem; 1999 Oct; 274(42):29826-30. PubMed ID: 10514461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays.
    Radtke KP; Griffin JH; Riceberg J; Gale AJ
    J Thromb Haemost; 2007 Jan; 5(1):102-8. PubMed ID: 17059431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa.
    Fay PJ; Smudzin TM
    J Biol Chem; 1992 Jul; 267(19):13246-50. PubMed ID: 1618828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exposed hydrophobic sites in factor VIII and isolated subunits.
    Sudhakar K; Fay PJ
    J Biol Chem; 1996 Sep; 271(38):23015-21. PubMed ID: 8798489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of factor VIII and mechanisms of cofactor action.
    Fay PJ
    Blood Rev; 2004 Mar; 18(1):1-15. PubMed ID: 14684146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL; Morrissey JH; Neuenschwander PF
    Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.
    Kosloski MP; Shetty KA; Wakabayashi H; Fay PJ; Balu-Iyer SV
    AAPS J; 2014 Sep; 16(5):1038-45. PubMed ID: 24934295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The A2 subunit of factor VIIIa modulates the active site of factor IXa.
    Fay PJ; Koshibu K
    J Biol Chem; 1998 Jul; 273(30):19049-54. PubMed ID: 9668086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Residues 110-126 in the A1 domain of factor VIII contain a Ca2+ binding site required for cofactor activity.
    Wakabayashi H; Freas J; Zhou Q; Fay PJ
    J Biol Chem; 2004 Mar; 279(13):12677-84. PubMed ID: 14722121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computational analysis of Asp519 and Glu665 mutations of coagulation factor FVIIIa: Implications for enhanced binding affinity of A2-domain.
    Shearin S; Venkateswarlu D
    J Mol Graph Model; 2017 Sep; 76():441-447. PubMed ID: 28780303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A3 domain residue Glu1829 contributes to A2 subunit retention in factor VIIIa.
    Wakabayashi H; Zhou Q; Varfaj F; Fay PJ
    J Thromb Haemost; 2007 May; 5(5):996-1001. PubMed ID: 17371488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.
    Varfaj F; Neuberg J; Jenkins PV; Wakabayashi H; Fay PJ
    Biochem J; 2006 Jun; 396(2):355-62. PubMed ID: 16503879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function.
    Lü J; Pipe SW; Miao H; Jacquemin M; Gilbert GE
    Blood; 2011 Mar; 117(11):3181-9. PubMed ID: 21156843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.
    Leong L; Sim D; Patel C; Tran K; Liu P; Ho E; Thompson T; Kretschmer PJ; Wakabayashi H; Fay PJ; Murphy JE
    Blood; 2015 Jan; 125(2):392-8. PubMed ID: 25331117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.